allogeneic hematopoietic stem cell transplantation
Showing 9976 - 10000 of >10,000
Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction
Active, not recruiting
- Metastatic Esophageal Adenocarcinoma
- +7 more
- Cixutumumab
- +3 more
-
Scottsdale, Arizona
- +232 more
Nov 16, 2022
NSCLC Trial in Zhengzhou (L-TIL, Tislelizumab, Docetaxel)
Recruiting
- Non-small Cell Lung Cancer
- L-TIL, Tislelizumab, Docetaxel
-
Zhengzhou, Henan, ChinaNo.127 Dongming Road
May 17, 2023
Advanced Solid Tumors Trial in Australia, New Zealand, Spain (BGB-A333, BGB-A317)
Terminated
- Advanced Solid Tumors
-
Clayton, Victoria, Australia
- +7 more
Oct 12, 2021
Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (drug, other, procedure)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Ramucirumab
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Dec 21, 2022
Prophylaxis Against Liver Transplant Rejection Trial in Germany (Tacrolimus Pill, Tacrolimus capsule)
Recruiting
- Prophylaxis Against Liver Transplant Rejection
- Tacrolimus Pill
- Tacrolimus capsule
-
Aachen, Germany
- +14 more
May 16, 2022
Diphtheria, Tetanus, Pertussis Trial in Xi'an (Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined
Not yet recruiting
- Diphtheria
- +2 more
- Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Aged 6 Years and Older) (Tdcp)
- +2 more
-
Xi'an, Shanxi, ChinaShaanxi Center for Disease Control and Prevention
Sep 25, 2023
Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1
Not yet recruiting
- Metastatic Clear Cell Renal Cell Carcinoma
- With Positive PSMA Expression at Tumor Sites
- 177Lu-PSMA-1 (radiopharmaceutical)
- (no location specified)
Sep 26, 2023
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Columbus
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Natural Killer Cell Therapy
- Temozolomide
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 28, 2022
TIGIT in Patients With Chronic Myeloid Leukemia
Not yet recruiting
- Chronic Myeloid Leukemia
- flow cytometry test
- (no location specified)
Mar 25, 2021
B-ALL, B-cell Non Hodgkin Lymphoma, DLBCL Trial in Stanford (Fludarabine, Cyclophosphamide, CD22 CAR)
Recruiting
- B-ALL
- +3 more
- Fludarabine
- +2 more
-
Stanford, CaliforniaStanford Medical Center
Jan 14, 2022
Small Cell Lung Cancer Limited Stage Trial in Germany (Durvalumab, standard of care)
Recruiting
- Small Cell Lung Cancer Limited Stage
- Durvalumab
- standard of care
-
Löwenstein, Baden-Würtemberg, Germany
- +9 more
May 18, 2022
Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous
Recruiting
- Oral Cavity Squamous Cell Carcinoma
-
Guangzhou, Guangdong, ChinaLiuxiqiang
Feb 1, 2023
Advanced Non Small Cell Lung Cancer Trial in Changsha (Toripalimab combination with platinum-containing dual-drug chemo)
Recruiting
- Advanced Non Small Cell Lung Cancer
- Toripalimab combination with platinum-containing dual-drug chemotherapy
-
Changsha, Hunan, ChinaHunan Provincal Tumor Hospital
Dec 28, 2021
Following Total Hip Arthroplasty With the SMF Stem
Terminated
- Joint Diseases
- Total hip arthroplasty
-
Berchem, Belgium
- +5 more
Feb 17, 2021
Adenocarcinoma of the Lung, Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer Trial in Aurora
Completed
- Adenocarcinoma of the Lung
- +7 more
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Jan 19, 2022
B-cell Lymphoma Trial in Hangzhou (PD1 specific integrated anti-CD19 Chimeric Antigen Receptor T Cells)
Active, not recruiting
- B-cell Lymphoma
- PD1 specific integrated anti-CD19 Chimeric Antigen Receptor T Cells
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of Med
Sep 28, 2022
COVID-19 Trial in Tashkent (Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells), Recombinant Novel
Recruiting
- COVID-19
- Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells)
- Recombinant Novel Coronavirus Protein Vaccine (CHO cells)
-
Tashkent, UzbekistanUzbekistan, Tashkent city, Said baraka street 10
Nov 11, 2022
Lupus Erythematosus, Systemic Trial in Netherlands (Belimumab Injection)
Recruiting
- Lupus Erythematosus, Systemic
- Belimumab Injection
-
Groningen, Netherlands
- +3 more
Mar 14, 2022
Pregnancy Related Trial in Houston (Redraw for analysis of blood samples from healthy pregnant women)
Recruiting
- Pregnancy Related
- Redraw for analysis of blood samples from healthy pregnant women
-
Houston, TexasLuna Genetics
Feb 16, 2022
Clear Cell Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial in Duarte
Recruiting
- Clear Cell Renal Cell Carcinoma
- +3 more
- Biospecimen Collection
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 19, 2023
NSCLC, EGF-R Positive NSCLC Trial in Wuxi (Parimparib, Chemotherapy drug, Targeted Therapy Agent)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- EGF-R Positive Non-Small Cell Lung Cancer
- Parimparib
- +2 more
-
Wuxi, Jiangsu, ChinaAffiliated Hospital of Jiangnan University
Jan 30, 2023
Osteo Arthritis Knee Trial in Salt Lake City (Amniotic Fluid Injection, Standard of Care)
Recruiting
- Osteo Arthritis Knee
- Amniotic Fluid Injection
- Standard of Care
-
Salt Lake City, UtahUniversity of Utah Orthopedic Center
Sep 7, 2021